Carlson College of Veterinary Medicine

S. Bae, Milovancev, M., Bartels, C., Irvin, V. L., Tuohy, J. L., Townsend, K. L., and Leeper, H., “Histologically low-grade, yet biologically high-grade, canine cutaneous mast cell tumours: A systematic review and meta-analysis of individual participant data.”, Vet Comp Oncol, vol. 18, no. 4, pp. 580-589, 2020.

H. M. Moulton, Hase, M. C., Smith, K. M., and Iversen, P. L., “HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers.”, Antisense & nucleic acid drug development, vol. 13, no. 1, pp. 31-43, 2003.

A. N. Reed, Izume, S., Dolan, B. P., Lapatra, S., Kent, M. L., Dong, J., and Jin, L., “Identification of B cells as a major site for cyprinid herpesvirus 3 latency.”, J Virol, vol. 88, no. 16, pp. 9297-309, 2014.

A. Reed, Izume, S., Dolan, B. P., Lapatra, S., Kent, M. L., Dong, J., and Jin, L., “Identification of B cells as a major site for koi herpesvirus (KHV) latency”, Journal of Virology, vol. 433, pp. 183-191, 2014.

A. Reed, Izume, S., Dolan, B. P., Lapatra, S., Kent, M. L., Dong, J., and Jin, L., “Identification of B cells as a major site for koi herpesvirus (KHV) latency”, Journal of Virology, vol. 433, pp. 183-191, 2014.

L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Chee, C. B., Aralar, P., Petrofsky, M., Parman, T., Green, C. E., Lewin, A. H., Ellis, W. Y., and Young, L. S., “Identification of (+)-Erythro-Mefloquine as an Active Enantiomer with Greater Efficacy than Mefloquine against Mycobacterium avium Infection in Mice.”, Antimicrobial agents and chemotherapy, vol. 56, no. 8, pp. 4202-6, 2012.

G. McClorey, Fall, A. M., Moulton, H. M., Iversen, P. L., Rasko, J. E., Ryan, M., Fletcher, S., and Wilton, S. D., “Induced dystrophin exon skipping in human muscle explants.”, Neuromuscular disorders : NMD, vol. 16, no. 9-10, pp. 583-90, 2006.

M. Milovancev, Tuohy, J. L., Townsend, K. L., and Irvin, V. L., “Influence of surgical margin completeness on risk of local tumour recurrence in canine cutaneous and subcutaneous soft tissue sarcoma: A systematic review and meta-analysis.”, Vet Comp Oncol, vol. 17, no. 3, pp. 354-364, 2019.

B. W. Neuman, Stein, D. A., Kroeker, A. D., Moulton, H. M., Bestwick, R. K., Iversen, P. L., and Buchmeier, M. J., “Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.”, Advances in experimental medicine and biology, vol. 581, pp. 567-71, 2006.

B. W. Neuman, Stein, D. A., Kroeker, A. D., Churchill, M. J., Kim, A. M., Kuhn, P., Dawson, P., Moulton, H. M., Bestwick, R. K., Iversen, P. L., and Buchmeier, M. J., “Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers.”, Journal of virology, vol. 79, no. 15, pp. 9665-76, 2005.

J. Yuan, Stein, D. A., Lim, T., Qiu, D., Coughlin, S., Liu, Z., Wang, Y., Blouch, R., Moulton, H. M., Iversen, P. L., and Yang, D., “Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site.”, Journal of virology, vol. 80, no. 23, pp. 11510-9, 2006.

T. S. Deas, Binduga-Gajewska, I., Tilgner, M., Ren, P., Stein, D. A., Moulton, H. M., Iversen, P. L., Kauffman, E. B., Kramer, L. D., and Shi, P. Y., “Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication.”, J Virol, vol. 79, no. 8, pp. 4599-609, 2005.

B. L. Geller, Deere, J. D., Stein, D. A., Kroeker, A. D., Moulton, H. M., and Iversen, P. L., “Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.”, Antimicrobial agents and chemotherapy, vol. 47, no. 10, pp. 3233-9, 2003.

M. Alonso, Stein, D. A., Thomann, E., Moulton, H. M., Leong, J. C., Iversen, P., and Mourich, D. V., “Inhibition of infectious haematopoietic necrosis virus in cell cultures with peptide-conjugated morpholino oligomers.”, Journal of fish diseases, vol. 28, no. 7, pp. 399-410, 2005.

C. Lupfer, Stein, D. A., Mourich, D. V., Tepper, S. E., Iversen, P. L., and Pastey, M., “Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers.”, Archives of virology, vol. 153, no. 5, pp. 929-37, 2008.

Q. Ge, Pastey, M., Kobasa, D., Puthavathana, P., Lupfer, C., Bestwick, R. K., Iversen, P. L., Chen, J., and Stein, D. A., “Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers.”, Antimicrobial agents and chemotherapy, vol. 50, no. 11, pp. 3724-33, 2006.

Y. - J. Zhang, Wang, K. - Y., Stein, D. A., Patel, D., Watkins, R., Moulton, H. M., Iversen, P. L., and Matson, D. O., “Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers.”, Antiviral research, vol. 73, no. 1, pp. 12-23, 2007.

B. P. Dolan, Phelan, T. P., Ilkovitch, D., Qi, L., Wade, W. F., Laufer, T. M., and Ostrand-Rosenberg, S., “Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines.”, Journal of immunology (Baltimore, Md. : 1950), vol. 172, no. 2, pp. 907-14, 2004.

L. E. Bermudez, Wu, M., Miltner, E., and Inderlied, C. B., “Isolation of two subpopulations of Mycobacterium avium within human macrophages.”, FEMS microbiology letters, vol. 178, no. 1, pp. 19-26, 1999.

M. R. Sarker, Sory, M. P., Boyd, A. P., Iriarte, M., and Cornelis, G. R., “LcrG is required for efficient translocation of Yersinia Yop effector proteins into eukaryotic cells.”, Infection and immunity, vol. 66, no. 6, pp. 2976-9, 1998.

J. E. Ishmael, Löhr, C. V., Fischer, K. A., and Kioussi, C., “Localization of myosin II regulatory light chain in the cerebral vasculature.”, Acta histochemica, vol. 110, no. 2, pp. 172-7, 2008.

A. Kumar Indra, Castaneda, E., Antal, M. Cristina, Jiang, M., Messaddeq, N., Meng, X., Löhr, C. V., Gariglio, P., Kato, S., Wahli, W., Desvergne, B., Metzger, D., and Chambon, P., “Malignant transformation of DMBA/TPA-induced papillomas and nevi in the skin of mice selectively lacking retinoid-X-receptor alpha in epidermal keratinocytes.”, The Journal of investigative dermatology, vol. 127, no. 5, pp. 1250-60, 2007.

L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S., “Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.”, Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.

L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S., “Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.”, The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.

P. L. Iversen, Mourich, D. V., and Moulton, H. M., “Monoclonal antibodies to two epitopes of beta-human chorionic gonadotropin for the treatment of cancer.”, Current opinion in molecular therapeutics, vol. 5, no. 2, pp. 156-60, 2003.